Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease

Israel Medical Association Journal

Volumn 6, Issue 4, 2004, Pages 227-232

  Weisman, Dalit ^a   Motro, Michael ^a   Schwammenthal, Ehud ^a   Fisman, Enrique Z ^a   Tenenbaum, Alexander ^a   Tanne, David ^a   Adler, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Coronary heart disease; Fish oil; Omega 3 fatty acids; Primary and secondary prevention

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ESTRIOL; GEMFIBROZIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; SIMVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIETARY INTAKE; DRUG RESPONSE; HEART ARREST; HEART DEATH; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MORTALITY; PRIMARY PREVENTION; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SIDE EFFECT; SUDDEN DEATH; BLOOD; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION;

CHOLESTEROL, LDL; CORONARY DISEASE; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; HYPERTRIGLYCERIDEMIA; MYOCARDIAL INFARCTION;

EID: 2342649438     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81(4A):7-12B.
2. Weber P, Raederstorff D. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids - a review. Nutr Metab Cardiovasc Dis 2000;10:28-37.
3. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-19.
4. Sprecher DL, Pearace GL, Cosgrove DM, Lytle BW, Loop FD, Pashkow FJ. Relation of serum triglyceride levels to survival after coronary artery bypass grafting. Am J Cardiol 2000;86:285-8.
5. Haim M, Benderly M, Brunner D, et al. for the BIP study group. Elevated serum triglyceride levels and long-term mortality in patients with CHD: the Bezafibrate Infarction Prevention (BIP) registry. Circulation 1999;100:475-82.
6. Tanne D, Koren-Morag N, Graff E, Goldbourt U. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (PIB) Registry: high triglycerides constitute an independent risk factor. Circulation 2001;104:2892-7.
7. Qureshi AI, Fareed K, Suri FK, Guterman LR, Hopkins LN. Ineffective secondary prevention in survivors of cardiovascular events in the US population. Arch Intern Med 2001;161:1621-8.
8. Mori TA, Beilin LJ. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001;12:11-17.
9. Calder PC. 3 Polyunsaturated fatty acids, inflammation and immunity. In: Hamazaki T, Okuyama H, eds. Fatty Acids and Lipids - New Finding. World Rev Nutr Diet 2001;88:109-16.
10. Leah A. Electophysiologic basis for the antiarrhythmic and anti-convulsant effects of 3 polyunsaturated fatty acids. World Rev Nutr Diet 2001;88:72-8.
11. Goodfellow J, Bellamy MF, Ramsey MW, Jones CJH, Lewis MJL. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000;35:265-70.
12. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003;361:477-85.
13. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346(15): 1113-18.
14. Marchioli R, for the GISSI-Prevention Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
15. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106: 2747-57.
16. Oomen CM, Feskens EJ, Rasanen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands Am J Epidemiol 2000;151(10):999-1006.
17. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary events. The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2000;102:2677-9.
18. Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 1997;66(4Suppl): 1020-31S.
19. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-8.
20. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 2000;17(Suppl):208-12S.
21. Nordoy A, Bonaa KH, Nilsen H, Berge RK, Hansen JB, Ingebretsen OC. Effects of simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidemia. Intern Med 1998;243:163-70.
22. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol 2000;20(1):259-65.
23. Calabresi L, la Donati D, Pazzucconi F, Sirtori CR, Franceschini G. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. Atherosclerosis 2000;148:387-96.
24. Stalenhoef AFH, de Graaf J, Wittekoek ME, Bredie SJH, Demacker PNM, Kastelein JJP. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia. Atherosclerosis 2000;153:129-38.
25. Stark KD, Park EJ, Maines VA, Holub BJ. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. Am J Clin Nutr 2000;72(2):389-94.
26. Kurabayashi T, Okada M, Tanaka K. Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group. Obstet Gynecol 2000;96(4):521-8.
27. Burr ML, Gilbert JF, Holliday RM, et al. Effects of changes in fat, fish and fiber intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989;ii:756-61.
28. GISSI Prevention Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention trial. Lancet 1999;354:447-55.
29. Bigger JT, El-Sherif T. Polyunsaturated fatty acids and cardiovascular events. A fish tale [Editorial]. Circulation 2001;103:623-5.
30. Van Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosos. A randomized, double-blind, placebo control trial. Ann Intern Med 1999;130(7):554-62.
31. Nilsen DWT, Albrektsen G, Landmaek K, Moen S, Aarsland T, Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylcerol and HDL cholesterol. Am J Clin Nutr 2001;74:50-6.
32. Durrington PN, Bhatnagar D, Mackness MI, Julier, Khan MA, France M. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglyceride in simbastatin treated patients with coronary heart disease and persisting hypertriglyceridemia. Heart 2001;85:544-8..
33. Benoit L, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk for ischemic heart disease in men. Circulation 1997;95:69-75.
34. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000;71:1085-94.
35. Higdon JV, Liu J, Du SH, Morrow JD, Ames BN, Wander RC. Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acids is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and (F(2)-isoprostanes. Am J Clin Nutr 2000;72(3):714-22.
36. Mabile L, Piolot A, Boulet L, et al. Moderate intake of w-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress Forth in hypertriglyceridemic subjects. Am J Clin Nutr 20001;74(4):449-56.
37. Pederson HS, Mulvad G, Seidelin KN, Malcom GT, Boudreau DA. N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet 1999;353:812-13.
38. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001;285:304-12.
39. Okeefe JH, Harris WS. Omega-3 fatty acids: time for clinical implementation? [Editorial]. Am J Cardiol 2000;85(10):1239-41.
40. Dyerberg J, Von Schacky C. 3 Fatty acids - from Eskimos to clinical cardiology: what took us so long? World Rev Nutr Diet 2001;88:90-9.